World's Best Scientists 2026 revealed!
Terrill K. McClanahan

Terrill K. McClanahan

D-Index & Metrics

Immunology

D-Index
71
Citations
63923
World Ranking
2263
National Ranking
1094

Terrill K. McClanahan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Terrill K. McClanahan sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 157 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Terrill K. McClanahan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Terrill K. McClanahan sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Terrill K. McClanahan is affiliated with MSD in the United States and has contributed to research primarily in the field of medicine, with a focus on oncology and related subfields. Their work encompasses a range of topics centered on cancer immunotherapy, sarcoma treatment, and medical imaging techniques.

The main fields of study in which they are active include:

  • Medicine

Within these, their research has explored several subfields such as:

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Surgery
  • Immunology
  • Radiology, Nuclear Medicine and Imaging

Key topics addressed in their work include:

  • Cancer Immunotherapy and Biomarkers
  • Sarcoma Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Esophageal Cancer Research and Treatment
  • Immune Cell Function and Interaction
  • Radiomics and Machine Learning in Medical Imaging

McClanahan has published studies in frequently encountered venues such as:

  • Clinical Cancer Research
  • International Journal of Radiation Oncology*Biology*Physics

Notable recent papers by McClanahan include:

  • Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types (2021, Clinical Cancer Research)
  • Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells (2022, Clinical Cancer Research)
  • A Radiomic Surrogate to Predict Tumor-Infiltrating CD8 T-Cells in Soft Tissue Sarcoma (2020, International Journal of Radiation Oncology*Biology*Physics)

They have collaborated with multiple coauthors on these studies, including:

  • Matthew B. Spraker
  • Stephanie K. Schaub
  • Wendy M. Blumenschein
  • Seth M. Pollack
  • Răzvan Cristescu

Best Publications

  • Involvement of chemokine receptors in breast cancer metastasis.

    Anja Müller;Bernhard Homey;Hortensia Soto;Nianfeng Ge

  • IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

    Claire L. Langrish;Yi Yi Chen;Wendy M Blumenschein;Jeanine D. Mattson

  • IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

    Jochen Schmitz;Alexander Owyang;Elizabeth Oldham;Yaoli Song

  • IFN- γ –related mRNA profile predicts clinical response to PD-1 blockade

    Mark Ayers;Jared Lunceford;Michael Nebozhyn;Erin Murphy

  • Development, cytokine profile and function of human interleukin 17-producing helper T cells

    Nicholas J Wilson;Katia Boniface;Jason R Chan;Brent S McKenzie

  • Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP

    Vassili Soumelis;Pedro A Reche;Holger Kanzler;Wei Yuan

  • Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy

    Razvan Cristescu;Robin Mogg;Mark Ayers;Andrew Albright

  • Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation

    Craig A. Murphy;Claire L. Langrish;Yi Yi Chen;Wendy M Blumenschein

  • Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

    Tanguy Y. Seiwert;Barbara Burtness;Ranee Mehra;Jared Weiss

  • IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6

    David Yen;Jeanne Cheung;Heleen Scheerens;Frédérique Poulet

  • TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

    Mandy J McGeachy;Kristian S Bak-Jensen;Yi Chen;Cristina M Tato

  • IL-27, a Heterodimeric Cytokine Composed of EBI3 and p28 Protein, Induces Proliferation of Naive CD4+ T Cells

    Stefan Pflanz;Jackie C Timans;Jeanne Cheung;Rency Rosales

  • A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R

    Christi Parham;Madaline Chirica;Jacqueline Timans;Elena Vaisberg

  • The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo

    Mandy J McGeachy;Yi Chen;Cristina M Tato;Arian Laurence

  • IL-23 promotes tumour incidence and growth

    John L. Langowski;Xueqing Zhang;Lingling Wu;Jeanine D. Mattson

  • IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells

    Jonathan P Sherlock;Barbara Joyce-Shaikh;Scott P Turner;Cheng-Chi Chao

  • IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis.

    Jason R. Chan;Wendy Blumenschein;Erin Murphy;Caroline Diveu

  • WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27

    Stefan Pflanz;Linda Hibbert;Jeanine Mattson;Rency Rosales

  • Multiplexed quantification of proteins and transcripts in single cells

    Vanessa M Peterson;Kelvin Xi Zhang;Namit Kumar;Jerelyn Wong

  • Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability

    Jacob S. Lee;Cristina M. Tato;Barbara Joyce-Shaikh;Muhammet F. Gulen

  • Anti–IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis

    Yi Chen;Claire L. Langrish;Brent Mckenzie;Barbara Joyce-Shaikh

Frequent Co-Authors

Robert A. Kastelein
Robert A. Kastelein MSD (United States)
Daniel J. Cua
Daniel J. Cua Johnson & Johnson (United States)
Lewis L. Lanier
Lewis L. Lanier University of California, San Francisco
Sandra Zurawski
Sandra Zurawski Baylor University
Linde Meyaard
Linde Meyaard Utrecht University
Gosse J. Adema
Gosse J. Adema Radboud University
Gerard Zurawski
Gerard Zurawski Baylor University
J. Fernando Bazan
J. Fernando Bazan Stanford University
Patrick A. Ott
Patrick A. Ott Harvard University
Donna Rennick
Donna Rennick MSD (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open diverse career opportunities. Nursing pathways, particularly Nurse Practitioner (NP) programs, offer a practical complement for applying immunological knowledge in patient care. For students seeking flexibility, the easiest np program options provide streamlined routes to licensure while maintaining rigorous training.

Specializing further, Psychiatric Mental Health Nurse Practitioner (PMHNP) programs emphasize mental health within immunological and neurological contexts. Those aiming for quality clinical training should explore the top online pmhnp programs, which boast excellent placement rates offering hands-on experience in diverse settings.

Cost is a significant consideration. Fortunately, several accredited programs are budget-friendly without compromising education quality. Reviewing the cheapest pmhnp programs can help prospective students find affordable pathways to advance their careers in immunology-related fields.

Advanced degrees like the Doctor of Nursing Practice (DNP) open doors to leadership and specialized clinical roles. Understanding dnp salary by specialty is crucial for evaluating return on investment and planning a sustainable career in healthcare.

Best Scientists Citing Terrill K. McClanahan

Trending Scientists

Recently Published Articles